RevOpsis Therapeutics Funding & Investors
RevOpsis Therapeutics has directed its efforts towards addressing vision loss. By utilizing their exclusive bispecific Surrobody platform, the company aims to target a diverse range of ocular conditions with potential therapeutic agents. The company was founded in 2022 and is based in Springfield, Illinois, United States.
revopsis.comTotal Amount Raised: $24,395,004
RevOpsis Therapeutics Funding Rounds
Seed
$9,000,000
Grant
$7,500,000
Series Unknown
$7,895,004
Funding info provided by Diffbot.